Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present BioSyent Inc. (OTC: BIOYF).

Full DD Report for BIOYF

You must become a subscriber to view this report.


Recent News from (OTC: BIOYF)

BioSyent Inc. 2018 Q3 - Results - Earnings Call Slides
The following slide deck was published by BioSyent Inc. in conjunction with their 2018 Q3 earnings Read more ...
Source: SeekingAlpha
Date: November, 21 2018 12:33
BioSyent -5.5% post Q3 results
BioSyent ( OTCPK:BIOYF -5.5% ) reports Q3  revenue decrease of 3% Y/Y to C$5.26M. More news on: BioSyent Inc., Stocks on the move, Read more ...
Source: SeekingAlpha
Date: November, 21 2018 11:39
BioSyent reports Q3 results
BioSyent ( OTCPK:BIOYF ): Q3 GAAP EPS of C$0.09. Revenue of C$5.26M (-3% Y/Y) Press Release More news on: BioSyent Inc., Earnings news and commentary, Consumer stocks news, ,
Source: SeekingAlpha
Date: November, 21 2018 08:09
BioSyent Inc. 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by BioSyent Inc. in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: August, 22 2018 13:12
BioSyent reports Q2 results
BioSyent ( OTCPK:BIOYF ): Q2 GAAP EPS of C$0.11. More news on: BioSyent Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 22 2018 08:04
BioSyent's (BIOYF) CEO Rene Goehrum on Q1 2018 Results - Earnings Call Transcript
BioSyent Inc (BIOYF) Q1 2018 Results Conference Call May 30, 2018 08:00 AM ET Executives Rene Goehrum - President & CEO Presentation Rene Goehrum Hello, and welcome to the Q1 2018 Results Presentation. My name is Rene Goehrum and I’m the President and CEO of BioS...
Source: SeekingAlpha
Date: May, 31 2018 14:27
BioSyent Inc. 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by BioSyent Inc. in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: May, 30 2018 13:56
BioSyent reports Q1 results
BioSyent ( OTCPK:BIOYF ): Q1 EPS of C$0.08 More news on: BioSyent Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 30 2018 08:05
BioSyent reports Q4 results
BioSyent ( OTCPK:BIOYF ): Q4 EPS of $0.10 More news on: BioSyent Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
Source: SeekingAlpha
Date: March, 21 2018 08:05
BioSyent: Will This Canadian Success Story Continue?
The Business BioSyent is a Canadian specialty pharmaceutical company focused on sourcing, commercializing, and further develop niche pharmaceutical and healthcare products with peak sales of <$20 million that are not yet available in Canada but is commercialized in other countrie...
Source: SeekingAlpha
Date: March, 09 2018 09:50

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-12N/A5.6942N/AN/A0
2018-12-115.645.69425.69425.64540
2018-12-105.805.805.805.67512,000
2018-12-075.80195.805.80195.801,264
2018-12-06N/A6.019N/AN/A50

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-102002,00010.0000Cover
2018-12-0410057,6400.1735Cover
2018-11-2620065030.7692Cover
2018-11-214,61815,96828.9203Cover
2018-11-1230054055.5556Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BIOYF.


About BioSyent Inc. (OTC: BIOYF)

Logo for BioSyent Inc. (OTC: BIOYF)

Not available

 

Contact Information

 

 

Current Management

  • Rene C. Goehrum / President, CEO
  • Rene C. Goehrum / Chairman

Current Share Structure

  • Market Cap: $99,218,000 - 03/16/2018
  • Issue and Outstanding: 13,300,000 - 06/06/2013

 



Daily Technical Chart for (OTC: BIOYF)

Daily Technical Chart for (OTC: BIOYF)


Stay tuned for daily updates and more on (OTC: BIOYF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BIOYF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BIOYF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BIOYF and does not buy, sell, or trade any shares of BIOYF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/